During the past decade, Instituto Português de Reumatologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Português de Reumatologia" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Universidade do Porto" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Amsterdam UMC, location VUmc" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Português de Reumatologia" #1 collaborator was "Centro de Investigação Interdisciplinar Egas Moniz" with 2 trials as a collaborator, "Portuguese Institute of Rheumatology" with 2 trials as a collaborator, "CHRC-Comprehensive Health Research Centre, FCM|NMS, UNL" with 1 trials as a collaborator, "Centro Hospitalar Baixo Vouga - Hospital Infante D. Pedro" with 1 trials as a collaborator and "Centro Hospitalar Lisboa Ocidental Hospital Egas Moniz" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Português de Reumatologia" are "Arthritis, Psoriatic" (2 trials), "Arthritis, Rheumatoid" (2 trials), "Sjogren's Syndrome" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Axial Spondyloarthritis" (1 trials). Many other conditions were trialed in "Instituto Português de Reumatologia" in a lesser frequency.

Most popular intervention types in "Instituto Português de Reumatologia" are "Drug" (8 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "General healthy eating" (2 trials), "Anti-inflammatory and low FODMAPs diet" (1 trials), "BI 695500" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Português de Reumatologia" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Instituto Português de Reumatologia". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Instituto Português de Reumatologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Português de Reumatologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".